论文标题
左旋多巴诱导的黑质毒性的计算模型Nigra pars compacta在帕金森氏病中
A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's Disease
论文作者
论文摘要
帕金森氏病(PD)是由黑质尼格拉pars compacta(SNC)的多巴胺能细胞逐渐丧失引起的。 PD中这种细胞丢失的根本原因仍未果断地阐明。最近的思维方式将PD神经退行性的原因带到了代谢缺陷。由于能量的需求异常高,SNC神经元表现出较高的基础代谢率和较高的氧气消耗率,从而导致氧化应激。最近,我们提出,SNC细胞的兴奋性丧失可能是由于能源缺乏在不同水平的神经层次结构上引起的。多巴胺的前体Levodopa(LDOPA)用作PD症状的治疗方法,可导致既积极又阴性的结果。一些研究人员认为,由于氧化应激,LDOPA可能对SNC细胞有害。 LDOPA在PD发病机理过程中的作用仍然值得讨论。我们假设能源缺乏可以通过两种方式导致LDOPA诱导的毒性(LIT):通过促进多巴胺诱导的氧化应激,并通过加剧SNC中的兴奋性兴奋性。我们提出了SNC-纹状体系统的多尺度计算模型,该模型将有助于我们理解上面假定的神经变性背后的机制,并为开发疾病调整治疗剂提供了见解。据观察,SNC终端比SNC Somas更容易受到能源缺乏的影响。在LDOPA治疗期间,观察到较高的LDOPA剂量会导致SNC中SOMAS和末端的损失增加。还观察到,LDOPA和谷胱甘肽(抗氧化剂)逃避LDOPA诱导的SNC神经元的毒性。我们表明,我们提出的模型能够捕获由能源缺乏引起的LDOPA诱导的SNC毒性。
Parkinson's disease (PD) is caused by the progressive loss of dopaminergic cells in substantia nigra pars compacta (SNc). The root cause of this cell loss in PD is still not decisively elucidated. A recent line of thinking traces the cause of PD neurodegeneration to metabolic deficiency. Due to exceptionally high energy demand, SNc neurons exhibit a higher basal metabolic rate and higher oxygen consumption rate, which results in oxidative stress. Recently, we have suggested that the excitotoxic loss of SNc cells might be due to energy deficiency occurring at different levels of neural hierarchy. Levodopa (LDOPA), a precursor of dopamine, which is used as a symptom-relieving treatment for PD, leads to outcomes that are both positive and negative. Several researchers suggested that LDOPA might be harmful to SNc cells due to oxidative stress. The role of LDOPA in the course of PD pathogenesis is still debatable. We hypothesize that energy deficiency can lead to LDOPA-induced toxicity (LIT) in two ways: by promoting dopamine-induced oxidative stress and by exacerbating excitotoxicity in SNc. We present a multiscale computational model of SNc-striatum system, which will help us in understanding the mechanism behind neurodegeneration postulated above and provides insights for developing disease-modifying therapeutics. It was observed that SNc terminals are more vulnerable to energy deficiency than SNc somas. During LDOPA therapy, it was observed that higher LDOPA dosage results in increased loss of somas and terminals in SNc. It was also observed that co-administration of LDOPA and glutathione (antioxidant) evades LDOPA-induced toxicity in SNc neurons. We show that our proposed model was able to capture LDOPA-induced toxicity in SNc, caused by energy deficiency.